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Tumor necrosis factor (TNF) was first identified during a study ofthe antitu-
mor activity present in sera of mice infected with bacillus Calmette-Guerin and
subsequently injected with endotoxin (1). TNF is a product ofactivated macro-
phages that has antitumor activity in vivo and in vitro (2). TNF has also been
implicated in the mediation of other activities associated with endotoxin, e.g.,
shock, cachexia (3). Human and mouse TNFs have been cloned and show ^-80%
homology (2, 3). Human lymphoblastoid cell lines also produce molecules [lym-
photoxin and TNF(LuKII)] with the full range ofTNF activities (4, 5). Lympho-
toxin has been cloned and shows -30% homology with TNF (6).
The standard in vitro assay for TNF involves mouse L cells, a transformed
fibroblast cell line (1). L cells can be selected for their resistance to TNF by
repeated exposure to TNF, and these resistant cells have been useful in distin-
guishing TNFs from other cytotoxic molecules (5). TNF-sensitive L cells have
receptors for TNF (7-10), and competition analysis studies show that mouse and
human TNF and TNF(LuKII) bind to the same receptor (7). In contrast, TNF-
resistant L cells (L,,) lack demonstrable cell surface receptors for TNF (7).
In the present study, we report that TNF-resistant L cells produce a factor
with the properties of mouse TNF.
Materials and Methods
BriefDefinitive Report
TNFs and Antibodies to TNFs.
￿
The production and purification of mouse TNF and
TNF(LuKII) were as described (11, 12). The serum of a rabbit immunized with pure
TNF(LuKII) served as a source of polyclonal antibody to TNF(LuKII). Human rTNF
and rabbit polyclonal antibody to pure human rTNF were kindly provided by Dr. Michael
Palladino, Genentech Inc. (South San Francisco, CA).
Production ofLR Cytotoxic Factor.
￿
LR cells seeded at a density of 5 X 105 cells in 150-
cm2 flasks were grown for 3 din Eagle's MEM (EMEM) containing 10% FBS. The medium
was then removed and replaced with EMEM containing no FBS. These cellswere allowed
to incubate for4 d at 37°C at which time the medium was harvested. This medium served
as a source of the L,, cytotoxic factor. When necessary, the medium was concentrated
using an Amicon cell (Amicon Corp., Lexington, MA) containing a YM-10 membrane.
This work was supported by grants CA-40614, CA-38661, and CA-08748 from the U. S. Public
Health Service, awarded by the National Cancer Institute.
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SDS-PAGE. SDS-PAGE was carried out in 18-cm slab gels according to published
methods (13).
In Vitro Cytotoxicity/TNF Assay.
￿
L cell cytotoxicity assays were performed as described
(12). Samples diluted twofold in 96-well microtiter plates were sterilized by ultraviolet
radiation and TNF-sensitive L cells were added to each well at a density of 2 X 10'
cells/well in 100 g1. After incubation for 2 d at 37'C, the plates were examined under a
microscope and the percentage of dead cells was determined. The number of units in a
sample was calculated as the reciprocal of the highest dilution that killed 50% of the cells.
All assays were run in parallel with a TNF laboratory standard, and all titers are expressed
in laboratory units.
Radioiodination of TNF(LuKII). TNF(LuKII) was labelled with "'I using 1,3,4,6-
tetrachloro-3a,6a-diphenylglycoluril (Iodogen; Pierce Chemical Co., Rockford, IL) as
described (7).
Assay for Binding of "'I-labelled TNF(LuKII) to Cells.
￿
TNF-sensitive L cells (LS) seeded
in 25-cm' flasks at a density of 2 X 106 cells/flask were allowed to adhere to the flasks for
24 h. The cells were then incubated at 4 0 C for 4 h with either 75 U/ml of radiolabelled
TNF(LuKII) alone (control) or with 75 U/ml ofradiolabelled TNF(LuKII) and increasing
amounts of the L,, cytotoxic factor. After 4 h, the cells were washed three times with cold
PBS, scraped from the flask in PBS, and centrifuged at 15,000 g for 5 min over a cushion
of PBS containing 5% sucrose. The sucrose cushion was then removed and the cell pellets
were counted in a gamma counter.
Results
TNF-resistant L cell lines were derived from the TNF-sensitive L(M) cloned
line by passage in partially purified TNF from mouse serum (11) or purified
TNF(LuKII) from the LuKII lymphoblastoid cell line (12). During initial passage,
>99% of the cells are killed by TNF, but after three to six additional passages in
TNF-containing medium, resistant L cells begin to predominant. During early
phases of TNF-resistance, cells revert to TNF-sensitivity if passaged in the
absence of TNF. However, after prolonged culture in TNF, the TNF-resistant
phenotype is stable and does not require continued exposure to TNF. L cells
made resistant to mouse TNF show crossresistance to TNF(LuKII) (and vice
versa) and to human rTNF. TNF-sensitive and TNF-resistant L cells have the
same fibroblast morphology by light and electron microscopy. Because identical
results were obtained with L cells made resistant to mouse TNF or TNF(LuKII),
we refer to the separately derived stable TNF-resistant L cell line as L.. The LR
cells used in these studies have been passaged for one year in TNF-free media.
Ls refers to TNF-sensitive L cells.
To determine whether the absence of demonstrable TNF receptors on LR cells
is due to their production of a factor that blocks TNF receptors, we compared
conditioned media from LR and LS cultures for their ability to compete with
radiolabelled TNF in TNF-binding assays. Supernatants from LR cultures but
not LS cultures showed strong TNF receptor-blocking activity. To determine
whether the TNF-blocking factor in L,, supernatants has cytotoxic activity, we
tested LR culture supernatants for the presence of a factor toxic to LS cells. Fig.
1 shows that L,, cells produce a factor that is released into the culture media and
kills LS cells. LR cells are not sensitive to LR media, and LS cells do not produce
cytotoxic factors for LS or LR cells. The LR cytotoxic factor was size-fractionated
on a G-100 Sephadex column, and was observed to have a molecular mass of 43
kD under nondenaturing conditions (Fig. 2). SDS-PAGE of this factor reveals
recovery of activity at a molecular mass of 16 kD under denaturing conditions
(Fig. 3) . These characteristics of the La factor closely resemble mouse TNF and1352
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FIGURE 1 .
￿
Accumulation of a cytotoxic factor in mediaconditioned by LR cells. Cells seeded
at a density of 2.5 x 105 in 75-cm2 flasks were allowed to grow for 7 d. On days 3, 5, and 7, a
sample of media was removed from cultures of La (A) and LS cells (0), and the cytotoxic
activity present in the media was measured in an in vitrocytotoxicity/TNF assay.
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FIGURE 2.
￿
Molecular mass determination of the cytotoxic activity present in LR-conditioned
medium. Medium conditioned by Le cells for 4 d was concentrated 10-fold using an Amicon
cell containing a YM-10 membrane, and was then applied to a 1 x 50-cm column bed of G-
100 superfine Sephadex (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated with PBS
(20 mM sodium phosphate, pH 7.0, 0.15 M NaCI). 1-ml fractions were collected and assayed
for the presence of the cytotoxic factor. The following proteins provided molecular mass
markers: BSA (67 kD), ovalbumin (43 kD), and soybean trypsin inhibitor (20 kD).
human TNF (2, 3). Neutralization tests with rabbit antisera to human rTNF
(which has neutralizing activity for mouse TNF) or to TNF(LuKII) are summa-
rized in Table I. The cytotoxic activity ofthe L,, factor is neutralized by antibody
against rTNF but not by antibody against TNF(LuKII). Competitive assays with
the LR factor indicate that it quantitatively competes for the same receptor as
TNF(LuKII) (Fig. 4), human rTNF, and non recombinant mouse TNF. In the
standard in vivo TNF assay, the LR factor induces necrosis of Meth A sarcoma
(Table II). The L,, factor also shows the characteristic TNF pattern of reactivityRUBIN ET AL.
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FIGURE 3.
￿
Recovery of cytotoxic activity from LR-conditioned medium after SDS-PAGE. A
50-ul sample of concentrated La-conditioned medium containing 700 cytotoxic units, adjusted
to contain 0.1 % SDS and 0.1 M 2-ME was incubated for 10 min at room temperature, and
then applied to a 12% SDS-polyacrylamide gel. After electrophoresis, the gel was sliced and
the activity was eluted and assayed. The following proteins provided molecular mass markers:
ovalbumin (43 kD), a-chymotrypsinogen (25 .7 kD), fl-lactoglobulin (18.4 kD), lysozyme (14.3
kD), and cytochrome c (12.3 kD).
TABLE I
Neutralization Assays ofthe L Cytotoxic Factor with Antisera
to TNF or TNF(LuKII)
Discussion
Samples of TNF(LuKII), human rTNF, and mouse serum TNF were mixed with either
20,000 neutralizing units of rabbit polyclonal antibody directed against pure TNF(LuKII),
20,000 neutralizing units ofrabbit polyclonal antibody directed against human rTNF, or no
antibody. The LR cytotoxic factor was mixed with either 5,000 neutralizingunits ofantibody
directed against TNF(LuKII), 5,000 neutralizing units of antibody directed against rTNF,
or no antibody. These samples were allowed to incubate for 1 h at 37°C and then assayed
for the presence of either TNF or the LR cytotoxic factor.
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on a panel of TNF-sensitive and TNF-resistant human cell lines (5, 14), and has
synergistic cytotoxic activity with interferon (5).
Mouse L cells selected for resistance to TNF were found to produce a cytotoxic
factor. This factor has biochemical and immunological characteristics of mono-
cyte-derived TNF, is capable of competing with TNF for receptor binding, and
causes the necrosis of the Meth A sarcoma in the in vivo TNF assay.
Several cell types of hematopoietic origin, including macrophages, lympho-
cytes, and lymphoblastoid cells, produce factors with TNF activity (2). Our
finding that nonhematopoietic cells of fibroblastic origin produce a molecule
with TNF activity indicates that TNF and TNF-related molecules may have a
role as mediators in cells outside the immune system. In this respect, the TNF
family of molecules resembles the interferon family, in that many cell types have
the capacity to produce interferons. IL-1, another mediator of macrophage
origin, is also known to be produced by nonimmunological cells. It will be
Factor added
Titer of TNF
No antiserum
or LR cytotoxic factor
Antiserum to
TNF(LuKII)
U/ml
in presence of
Antiserum to
rTNF
TNF(LuKII) 16,000 <6 16,000
rTNF 20,000 20,000 <6
Mouse serum TNF 20,000 20,000 <6
Lit cytoxic factor 3,200 3,200 <61354 RUBIN ET AL.
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FIGURE 4. Competitive binding of '2-1I-labelled TNF(LuKII) by the Lx cytotoxic factor.
Receptor binding studies were performed as described in Materials and Methods. All values
presented are expressed as a percentage ofthe radiolabelled TNF(LuKII) bound in the absence
of the Ln factor.
TABLE II
Induction ofHemorrhagic Necrosis ofBALE/c Sarcoma Meth A by the
L,, cytotoxicfactor
(BALB/c X C57BL/6)F, female mice were injected intradermally with 5 X 105 Meth A
BALB/c sarcoma cells. After 7 d, mice received a single intratumoral injection of concen-
trated media conditioned by L,, or Ls cells, human rTNF, mouse serum TNF, or
TNF(LuKII). After 24 h, tumor hemorrhagic necrosis was scored according to Carswell et
al. (1). All materials injected contained <45 ng of endotoxin as measured in Limulus
amebocyte lysate assays (Associates ofCape Cod, Inc., Woods Hole, MA).
important to determine the full range ofcell types capable of TNF production,
either constitutively, after induction with chemical agents, or after viral or
bacterial infection.
Although we have repeatedly isolated TNF-resistant L cells from TNF-sensi-
tivepopulations ofL cells, wedo not know whether the resistant variants preexist
and are selected by TNF, or whether TNF resistance can be induced in sensitive
cells. Attempts to isolate uniformly resistant cells from other TNF-sensitive cell
types, e.g., BT-20 and HeLa, have not been successful. With the finding that
TNF-resistant L cells produce TNF, the lack ofdemonstrable TNF-binding sites
on these cells (7) could have several explanations, including saturation of TNF
receptors, downregulation of TNF receptors, or selection of receptor-negative
cells. Whatever the reason, theproduction ofTNF by cells selected for resistance
to TNF represents a novel mechanism ofcellular resistance.
Summary
TNF-resistant lines of L cells can be derived from TNF-sensitive populations
by repeated exposure to TNF, and these resistant L cells, in contrast to sensitive
L cells and other types ofcells, lack demonstrable cell surface receptors for TNF.
Source of Material Number
of mice Units injected Necrotic reaction
Ls cells 3 2,500 ... ... ..
Ls cells 3 - - - -
rTNF 3 1,000 .... .... ...
Mouse TNF 5 4,800 .... .... .... ... ..
TNF(LuKII) 2 5,000 .... ..RUBIN ET AL.
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We have now found that TNF-resistant L cells produce a factor that is cytotoxic
for L cells and has the following distinguishing characteristics of mouse TNF : it
is a protein of 43 kD, composed of 16 kD subunits, that competes with TNF for
receptor binding, induces hemorrhagic necrosis of the TNF-sensitive mouse
sarcoma Meth A, has synergistic cytotoxic action with interferon, and its activity
is neutralized by antibody to TNF. The two conclusions of this study are that
cells selected for TNF resistance spontaneously produce a molecule resembling
macrophage TNF, and that cells of nonhematopoietic origin are capable of
producing TNF.
We thank Chris Watklevicz for assistance in preparing this manuscript.
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